Vaccine · BLA
Menactra NDC 49281-589
Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen 4 ug/.5mL + 3 more ingredients · Injection, Solution · Intramuscular · Sanofi Vaccines US Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 49281-589-05 | 4928105890549281058905 | 5 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-589-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-589-58)Marketed from Jan 14, 2005 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Menactra
- Generic name (nonproprietary)
- neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen
- Active ingredients
- Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen — 4 ug/.5mLNeisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen — 4 ug/.5mLNeisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen — 4 ug/.5mLNeisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen — 4 ug/.5mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Labeler
- Sanofi Vaccines US Inc.NDC labeler code 49281
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125089
- Marketing start
- Listing expires
- Other FDA classes
- Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Meningococcal Vaccines (Chemical structure)Meningococcal Vaccines (Chemical structure)Meningococcal Vaccines (Chemical structure)Meningococcal Vaccines (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
- Identifiers
- Product ID 49281-589_271ed59c-a374-4fc0-bb92-d13fbdabdeefSPL ID 271ed59c-a374-4fc0-bb92-d13fbdabdeef
- Pharmacologic class
- Inactivated Meningococcal Vaccine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N449281058905followed by a unit qualifier and the quantityPackage 49281-0589-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 49281-589
- What is NDC 49281-589?
- 49281-589 is the product NDC for Menactra, Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen 4 ug/.5mL + 3 more ingredients injection, solution, listed with the FDA by Sanofi Vaccines US Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Menactra (NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN).
- What is the active ingredient?
- Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen.
- Who is the labeler?
- Sanofi Vaccines US Inc., NDC labeler code 49281. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Menactra?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.